Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ · Healthcare
Indivior Pharmaceuticals, Inc. Net Income 2022–2025
Indivior Pharmaceuticals, Inc. annual/quarterly net income history and growth rate from 2022 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Indivior Pharmaceuticals, Inc. net income for the quarter ending March 31, 2026 was 89.0 M, a 89.36% increase year-over-year.
- Indivior Pharmaceuticals, Inc. net income for the twelve months ending March 31, 2026 was 196.0 M.
- Indivior Pharmaceuticals, Inc. annual net income for 2025 was 210.0 M, a 2900.00% increase from 2024.
- Indivior Pharmaceuticals, Inc. annual net income for 2024 was 7.0 M, a 105.56% decrease from 2023.
- Indivior Pharmaceuticals, Inc. annual net income for 2023 was -126.0 M, a 186.36% increase from 2022.
- Indivior Pharmaceuticals, Inc. annual net income for 2022 was -44.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Indivior Pharmaceuticals, Inc. Net Income — FAQ
Indivior Pharmaceuticals, Inc. (INDV) net income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Indivior Pharmaceuticals, Inc.'s net income?
Indivior Pharmaceuticals, Inc. (INDV) reported net income of $210M for fiscal 2025.
Where can I see INDV's net income history?
The chart and table above show Indivior Pharmaceuticals, Inc.'s net income by year and by quarter, including the growth rate.